Workflow
股份回购
icon
Search documents
杭州民生健康第二期回购计划进展:截至11月底暂未实施 拟回购210万-240万股
Xin Lang Zheng Quan· 2025-12-02 11:55
Core Points - Hangzhou Minsheng Health Pharmaceutical Co., Ltd. has announced the progress of its second share repurchase plan, revealing that as of November 30, 2025, no shares have been repurchased, representing 0.00% of the company's total share capital [1][3] Summary by Sections Repurchase Plan Overview - The second share repurchase plan was approved by the company's board on October 28, 2025, with a maximum repurchase price set at 21.06 CNY per share, which is 150% of the average trading price over the previous 30 trading days [2] - The expected number of shares to be repurchased ranges from 2.1 million to 2.4 million shares, with a total estimated repurchase fund not exceeding 50.544 million CNY [2] Implementation Progress - As of November 30, 2025, the company has not conducted any repurchase operations, citing market conditions as the reason for the lack of activity [3] - The company is adhering to regulations regarding share repurchases, including avoiding repurchases during significant market events or periods prohibited by regulatory authorities [3] Future Plans - The company intends to continue pursuing the repurchase plan within the designated timeframe and will fulfill its information disclosure obligations as required by law [4] - The implementation of the repurchase plan may face uncertainties, and the company has previously disclosed multiple share repurchase plans, indicating ongoing market interest [4]
国投资本:已累计回购公司股份45.61万股,支付总金额约为349.93万元
Bei Jing Shang Bao· 2025-12-02 11:18
北京商报讯(记者 刘宇阳)12月2日,国投资本发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示,截 至11月28日,公司已累计回购股份45.61万股,占公司总股本的比例为0.0071%,购买的最高价为7.71元/股,最低价为 7.58元/股,已支付的总金额约为349.93万元(不含交易费用)。 回顾2025年4月9日,国投资本召开董事会审议通过了《关于以集中竞价交易方式回购公司A股股份的议案》,同意公司 以集中竞价交易方式回购公司发行的部分人民币普通股(A股),回购资金总额不低于人民币2亿元(含),不超过人 民币4亿元(含),回购股份实施期限为自公司董事会审议通过该次回购股份方案之日起12个月内。 | 回购方案首次披露日 | 2025/4/10 | | --- | --- | | 回购方案实施期限 | 2025年4月9日~2026年4月8日 | | 预计回购金额 | 20,000万元~40,000万元 | | 回购用途 | □减少注册资本 | | | □用于员工持股计划或股权激励 | | | √用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 456.100股 ...
天合光能:累计斥资6.92亿元回购1.6%股份
Ge Long Hui A P P· 2025-12-02 10:45
Core Viewpoint - Trina Solar announced a share repurchase plan starting on June 25, 2024, which has been extended to March 24, 2026, with funding sourced from its own and raised funds [1] Group 1: Share Repurchase Details - The company plans to repurchase shares worth 100 million to 120 million yuan for the purpose of converting convertible bonds [1] - As of November 30, 2025, the company has repurchased a total of 37,377,953 shares, representing 1.60% of the total share capital [1] - The highest transaction price during the repurchase was 24.91 yuan per share, while the lowest was 13.64 yuan per share, with total funds paid amounting to 692 million yuan [1]
九源基因拟斥资最多1亿元回购股份
Zhi Tong Cai Jing· 2025-12-02 10:40
Core Viewpoint - The company plans to repurchase up to RMB 100 million worth of H-shares in the open market, reflecting confidence in its intrinsic value and growth potential [1] Group 1: Share Repurchase Plan - The board has resolved to use up to RMB 100 million to repurchase approximately 10.9097 million H-shares from the date of this announcement until the expiration of the repurchase authorization [1] - The actual repurchase price for each H-share will not exceed a premium of 5% over the average closing price of the H-shares for the five trading days preceding each repurchase [1] - Shares repurchased may be canceled, held as treasury shares, or used for share incentive plans [1] Group 2: Financial Health and Market Confidence - The company currently has a robust cash flow and stable overall financial condition, which can support its ongoing business development needs [1] - The board believes that the current trading price of the shares does not adequately reflect the company's intrinsic value and business prospects [1] - The share repurchase is seen as a demonstration of the company's and management's confidence in its business development and growth potential, ultimately benefiting the company and creating value for shareholders [1]
中远海控累计回购约5000万股 耗资7.48亿元
Zhi Tong Cai Jing· 2025-12-02 09:07
中远海控(601919)(601919.SH)发布公告,截至2025年11月30日,公司通过上海证券交易所交易系统 以集中竞价交易方式累计回购A股股份约5000万股,占公司截至2025年11月30日总股本的比例为 0.323%,购买的最高价为人民币14.98元/股、最低价为人民币14.86元/股,已支付的总金额为人民币7.48 亿元(不含交易费用)。 ...
蓝思科技:已回购730.96万股,使用资金总额2.12亿元
Xin Lang Cai Jing· 2025-12-02 08:53
蓝思科技12月2日公告,公司于2025年4月7日召开第五届董事会第四次会议,审议通过了《关于回购公 司股份方案的议案》,同意公司使用自有资金或自筹资金以集中竞价交易方式,回购公司部分已发行的 普通股(A股)股份,用于实施员工持股计划或股权激励计划。本次回购金额不低于5亿元(含)且不 超过10亿元(含),回购股份价格上限为34.5元/股,回购股份期限为自公司董事会审议通过本次回购 股份方案之日起12个月内。截至2025年11月30日,公司累计回购730.96万股,占公司总股本的0.15%, 回购价格区间为22.5元/股至30.24元/股,累计使用资金2.12亿元(不含交易费用)。 ...
杰瑞股份:截至11月末累计斥资1.06亿元回购股份
Xin Lang Cai Jing· 2025-12-02 08:51
Core Viewpoint - The company plans to repurchase shares between 150 million to 250 million yuan as part of its 2025 share repurchase program, aimed at employee stock incentives or employee shareholding plans, with a maximum repurchase price adjusted to 48.16 yuan per share due to equity distribution [1] Summary by Sections Share Repurchase Plan - The company announced a share repurchase plan for 2025, intending to buy back shares worth 150 million to 250 million yuan [1] - The maximum repurchase price is set at 49 yuan per share, later adjusted to 48.16 yuan per share [1] Current Repurchase Status - As of November 30, the company has repurchased 3.0875 million shares, representing 0.30% of the total share capital [1] - The highest transaction price recorded was 38.65 yuan per share, while the lowest was 33.67 yuan per share, with a total transaction amount of 106 million yuan [1] Future Actions - The company will continue to implement the repurchase plan within the designated timeframe and will disclose further information as necessary [1]
百傲化学:累计回购1.99亿元股份用于员工持股或激励
Xin Lang Cai Jing· 2025-12-02 08:39
Core Viewpoint - The company announced a share repurchase plan aimed at utilizing 200 to 400 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 31.67 yuan per share over a 12-month period [1] Group 1 - The company plans to repurchase shares starting from April 24, 2025, with a budget of 200 to 400 million yuan [1] - As of November 2025, the company has repurchased 2.5281 million shares, accounting for 0.36% of the total share capital, at a cost of 78.9848 million yuan [1] - By November 30, 2025, the cumulative repurchase reached 8.1888 million shares, representing 1.16% of the total share capital, with a total expenditure of 199 million yuan [1]
德邦股份:拟7500万至1.5亿元回购股份,已回购近2000万元
Xin Lang Cai Jing· 2025-12-02 08:37
德邦股份公告称,公司于2025年4月24日、5月16日分别经董事会、股东会审议通过回购股份预案,预计 回购金额7500万元至1.5亿元,回购价格上限不超15.85元/股,用途为减少注册资本。截至2025年11月 底,公司已累计回购股份136.23万股,占总股本0.13%,支付总金额1999.72万元,回购价格区间为14.31 元/股至15.04元/股。 ...
近岸蛋白:拟1000万-2000万元回购股份,暂未开展回购
Xin Lang Cai Jing· 2025-12-02 08:32
Core Viewpoint - The company announced a share repurchase plan approved at the shareholder meeting on October 15, 2024, with a budget of 10 million to 20 million yuan for reducing registered capital, with a repurchase price not exceeding 30.68 yuan per share [1] Group 1 - The initial repurchase period was set to end on October 15, 2025, but was extended by six months to April 13, 2026 [1] - As of November 30, 2025, the company has not yet initiated the share repurchase and will implement it at an opportune time [1]